LncRNA LOXL1‐AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR‐423‐5p and targeting MYBL2-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

LncRNA LOXL1‐AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR‐423‐5p and targeting MYBL2

Published:2019-11-23 Issue:2 Volume:9 Page:689-699
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Li Wei¹^ORCID,Zhang Biao¹,Jia Youchao²,Shi Hongyun³,Wang Haibo¹,Guo Qiang¹,Li Hefei¹

Affiliation:

1. Department of Thoracic Surgery Affiliated Hospital of Hebei University Baoding China

2. Department of Medical Oncology Affiliated Hospital of Hebei University Baoding China

3. Department of Radiation Oncology Affiliated Hospital of Hebei University Baoding China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2641

Reference33 articles.

1. Cancer statistics, 2017

2. Lung Cancer Screening Beyond Low-Dose Computed Tomography: The Role of Novel Biomarkers

3. The 2015 WHO classification of lung tumors

4. Non-small-cell lung cancer

5. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive review on lncRNA LOXL1-AS1: molecular mechanistic pathways of lncRNA LOXL1-AS1 in tumorigenicity of cancer cells;Frontiers in Oncology;2024-07-29

2. Differential expression and clinical significance of long non-coding RNAs in the development and progression of lung adenocarcinoma;Frontiers in Oncology;2024-06-06

3. Involvement of long non-coding RNA LOXL1-AS1 in the tumourigenesis and development of malignant tumours: a narrative review;Translational Cancer Research;2024-06

4. Long non-coding RNA LOXL1-AS1: a potential biomarker and therapeutic target in human malignant tumors;Clinical and Experimental Medicine;2024-05-02

5. Potential role of lncRNA LOXL1-AS1 in human cancer development: a narrative review;Translational Cancer Research;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3